A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
Clinical trial NCT00085826 · COMPLETED
Trial details
- NCT number
- NCT00085826
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.